Key Bridge Compliance, LLC Citius Pharmaceuticals, Inc. Transaction History
Key Bridge Compliance, LLC
- $319 Billion
- Q3 2023
A detailed history of Key Bridge Compliance, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, Key Bridge Compliance, LLC holds 154,130 shares of CTXR stock, worth $234,277. This represents 0.03% of its overall portfolio holdings.
Number of Shares
154,130Holding current value
$234,277% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CTXR
# of Institutions
6Shares Held
2.04MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY1.81MShares$2.74 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ40.3KShares$61,2300.0% of portfolio
-
Ifp Advisors, Inc33.3KShares$50,6660.0% of portfolio
-
American Portfolios Advisors Holbrook, NY4KShares$6,0800.0% of portfolio
-
Clear Perspectives Financial Planning, LLC Cincinnati, OH400Shares$6080.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $222M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...